243 related articles for article (PubMed ID: 17198938)
1. Lipid metabolism in chronic kidney disease: the role of statins in cardiovascular risk.
Wanner C; Drechsler C; Krane V
J Ren Nutr; 2007 Jan; 17(1):75-8. PubMed ID: 17198938
[TBL] [Abstract][Full Text] [Related]
2. Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence.
Kanbay M; Turgut F; Covic A; Goldsmith D
J Nephrol; 2009; 22(5):598-609. PubMed ID: 19809992
[TBL] [Abstract][Full Text] [Related]
3. The unique character of cardiovascular disease in chronic kidney disease and its implications for treatment with lipid-lowering drugs.
Nogueira J; Weir M
Clin J Am Soc Nephrol; 2007 Jul; 2(4):766-85. PubMed ID: 17699494
[TBL] [Abstract][Full Text] [Related]
4. [Chronic kidney disease and statins].
Matovinović MS
Lijec Vjesn; 2006; 128(11-12):345-50. PubMed ID: 17212196
[TBL] [Abstract][Full Text] [Related]
5. Dyslipidemia, inflammation and dialysis outcomes: what we know now.
Krane V; Drechsler C; Wanner C
Curr Opin Nephrol Hypertens; 2006 Nov; 15(6):566-70. PubMed ID: 17053468
[TBL] [Abstract][Full Text] [Related]
6. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
7. Managing dyslipidemia in chronic kidney disease.
Harper CR; Jacobson TA
J Am Coll Cardiol; 2008 Jun; 51(25):2375-84. PubMed ID: 18565393
[TBL] [Abstract][Full Text] [Related]
8. Statins and cardiovascular risk reduction in patients with chronic kidney disease and end-stage renal failure.
Baber U; Toto RD; de Lemos JA
Am Heart J; 2007 Apr; 153(4):471-7. PubMed ID: 17383281
[TBL] [Abstract][Full Text] [Related]
9. Lipid management in chronic kidney disease, hemodialysis, and transplantation.
Montague T; Murphy B
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):223-34. PubMed ID: 19217521
[TBL] [Abstract][Full Text] [Related]
10. Plasma lipoprotein abnormalities in hemodialysis patients--clinical implications and therapeutic guidelines.
Shoji T; Nishizawa Y
Ther Apher Dial; 2006 Aug; 10(4):305-15. PubMed ID: 16911182
[TBL] [Abstract][Full Text] [Related]
11. Dyslipidemia in chronic kidney disease: are statins still indicated in reduction cardiovascular risk in patients on dialysis treatment?
Scarpioni R; Ricardi M; Melfa L; Cristinelli L
Cardiovasc Ther; 2010 Dec; 28(6):361-8. PubMed ID: 20553296
[TBL] [Abstract][Full Text] [Related]
12. Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment.
Tsimihodimos V; Dounousi E; Siamopoulos KC
Am J Nephrol; 2008; 28(6):958-73. PubMed ID: 18612199
[TBL] [Abstract][Full Text] [Related]
13. The dyslipidemia of chronic renal disease: effects of statin therapy.
Ozsoy RC; van Leuven SI; Kastelein JJ; Arisz L; Koopman MG
Curr Opin Lipidol; 2006 Dec; 17(6):659-66. PubMed ID: 17095911
[TBL] [Abstract][Full Text] [Related]
14. Lipid changes and statins in chronic renal insufficiency.
Ritz E; Wanner C
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S226-30. PubMed ID: 17130266
[TBL] [Abstract][Full Text] [Related]
15. Management of dyslipidemias in patients with diabetes and chronic kidney disease.
Molitch ME
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1090-9. PubMed ID: 17699330
[TBL] [Abstract][Full Text] [Related]
16. Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease.
Kendrick J; Chonchol MB
Nat Clin Pract Nephrol; 2008 Dec; 4(12):672-81. PubMed ID: 18825155
[TBL] [Abstract][Full Text] [Related]
17. [Statins in chronic renal disease].
Ferreira SR; Rocha AM; Saraiva JF
Arq Bras Cardiol; 2005 Oct; 85 Suppl 5():45-9. PubMed ID: 16400399
[TBL] [Abstract][Full Text] [Related]
18. Management of dyslipidemia in renal disease and transplantation.
Zolezzi M
Saudi J Kidney Dis Transpl; 2006 Jun; 17(2):129-36. PubMed ID: 16903617
[No Abstract] [Full Text] [Related]
19. Lipid abnormalities and cardiovascular risk in renal disease.
Ritz E; Wanner C
J Am Soc Nephrol; 2008 Jun; 19(6):1065-70. PubMed ID: 18369085
[TBL] [Abstract][Full Text] [Related]
20. New insights into lipid metabolism in chronic kidney disease: what are the practical implications?
Kaysen GA
Blood Purif; 2009; 27(1):86-91. PubMed ID: 19169024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
